Follow-up and early detection for kids at risk of type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study follows children who are at genetic risk for type 1 diabetes or have early immune signs (autoantibodies) but do not yet need insulin. It provides extra checkups and information to catch the disease early and help families understand their child's risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 0 and 18 years old
- Your child has either a high or moderate genetic risk for type 1 diabetes (based on a special blood test) OR has tested positive for one or more early immune signs (autoantibodies) of type 1 diabetes
- Your child has not yet reached stage 3 type 1 diabetes (the stage where insulin is needed)
- Your child is not currently enrolled in another type 1 diabetes prevention study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is designed to help identify and monitor people at high risk for type 1 diabetes. It involves education and regular check-ups to better understand and manage the condition.
This study tests whether a program of diet and activity advice for families can lower the risk of type 1 diabetes in infants who have a higher genetic chance of developing it. It aims to find simple, everyday ways to help protect your child.
This study checks for specific blood markers (“islet autoantibodies”) to find children who may be at risk for developing type 1 diabetes later, before symptoms start. It’s mainly for children who have no known diabetes yet.
This study looks for people at high risk of developing type 1 diabetes (based on family history or blood markers) and follows them over time to understand disease development. The goal is to eventually prevent or delay type 1 diabetes in people who don't have it yet.
This study looks at immune system cells and gene activity in infants and young children to understand what causes type 1 diabetes to start so early. It may help researchers find earlier warning signs and better ways to support families right at diagnosis.
This study tests a screening program that looks for early signs of type 1 diabetes in children ages 2 to 10. It aims to find kids at risk as early as possible so they can get care sooner.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.